Threshold
← Landscape

Trial NCT07403812

Assessing DCog Short for Neurotoxicity in CAR-T

Phase
Not given
Sponsor
Beth Israel Deaconess Medical Center
Conditions
Neurotoxicity; Neurotoxicity Syndromes; Hematologic Malignancy; Immune Effector Cell Associated Neurotoxicity Syndrome
Ages
18+ years
View on ClinicalTrials.gov ↗

Eligibility criteria

Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).

Inclusion Criteria: * participants treated with CART-Cell therapy as described above and therefore at risk for treatment associated neurotoxicity. * Visual acuity of 20/100 or better. Exclusion Criteria: * patients < 18 years old * pregnant womenPregnancy * prisoners * adults unable to consent, * participants unwilling to use iPad-based tools. Severe motor deficits that can prevent patients from using an iPad

Restrictions found (1)

Recruiting in Massachusetts

  • Beth Israel Deaconess Medical Center · Boston, Suffolk County